Tradestie Institutional Equity Comparison Engine
DXCM vs IDXX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DXCM Overall Edge
DXCM Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Valuation, Momentum & Technical while IDXX counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, DXCM trades at 25.3x Forward P/E with 24.0% operating margin (+11.2% YoY revenue) versus IDXX at 40.0x Forward P/E and 32.5% operating margin (+9.9% YoY). In options structure, DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against IDXX sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DXCM
DXCM 25.3x vs IDXX 40.0x Fwd P/E
Growth & Margin Winner
IDXX
Op Margin 24.0% vs 32.5% ยท YoY +11.2% vs +9.9%
Momentum & Technical Winner
DXCM
1Y +32.8% vs -3.0% ยท 52W Pos 63% vs 65%
Options & Structure Winner
IDXX
CONSOLIDATION (15th %ile IV) vs SURGE (34th %ile IV)
DXCM
NASDAQ
DexCom, Inc.
Surgical & Medical Instruments & Apparatus
$79.32
-1.08% 1D
Market Cap
$29.9B
1M Return
+1.28%
1Y Return
+32.8%
Forward P/E
25.3x
Unified AI Score
50.8 / 100
HOLD
Tech 49.0
Fund 56.0
Flow 68.0
Mom 54.0
IDXX
NASDAQ
Idexx Laboratories Inc
In Vitro & In Vivo Diagnostic Substances
$676.21
-1.95% 1D
Market Cap
$54.3B
1M Return
+19.31%
1Y Return
-3.0%
Forward P/E
40.0x
Unified AI Score
44.3 / 100
HOLD
Tech 23.0
Fund 48.0
Flow 70.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DXCM +32.8%
IDXX -3.0%
Spread: +35.8 pp (DXCM Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DXCM Revenue | IDXX Revenue | DXCM Op. Margin | IDXX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.03B | $2.21B | -18.1% | 22.2% | IDXX |
| FY2019 | $1.48B | $2.41B | 9.6% | 23.0% | IDXX |
| FY2020 | $1.93B | $2.71B | 15.5% | 25.7% | IDXX |
| FY2021 | $2.45B | $3.22B | 10.9% | 29.0% | IDXX |
| FY2022 | $2.91B | $3.37B | 13.4% | 26.7% | IDXX |
| FY2023 | $3.62B | $3.66B | 16.5% | 30.0% | IDXX |
| FY2024 | $4.03B | $3.90B | 14.9% | 29.0% | IDXX |
| FY2025 | $4.66B | $4.30B | 19.6% | 31.6% | IDXX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DXCM | IDXX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9B | $54.3B | Larger Scale | IDXX |
| Trailing P/E Ratio Valuation | 31.6x | 46.5x | Lower Multiple | DXCM |
| Forward P/E Ratio Valuation | 25.3x | 40.0x | Lower Multiple | DXCM |
| Revenue Growth (YoY) Growth | +11.2% | +9.9% | Higher Growth | DXCM |
| Operating Margin (TTM) Profitability | 24.0% | 32.5% | Higher Margin | IDXX |
| Net Profit Margin Profitability | 19.4% | 25.4% | Higher Margin | IDXX |
| Return on Equity (ROE) Capital Efficiency | 37.7% | 68.9% | Higher ROE | IDXX |
| 52-Week Range Position Momentum | 63% ($57โ$93) | 65% ($501โ$770) | Stronger Trend | IDXX |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 43% Vol | 0.61ฮฒ ยท 81% Vol | Lower Realized Risk | DXCM |
| Unified Institutional Score Composite Signal | 50.8 / 100 (HOLD) | 44.3 / 100 (HOLD) | Higher Composite | DXCM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DXCM vs IDXX Buy Guide
DXCM
CONSOLIDATION
73d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
IDXX
SURGE
9d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DXCM nor IDXX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.